Carle Cancer Center NCI Community Oncology Research Program

Urbana, Illinois 61801

1 studies enrolling now · 13 studies all time

What they study most

Anatomic Stage IV Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Adenocarcinoma, Breast Carcinoma, Breast Inflammatory Carcinoma, Chemoradiation, Chemotherapy-Induced Peripheral Neuropathy, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8

Studies at this site

• Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer — Recruiting now
• Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer — Recruiting now
• Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer — Running, not enrolling
• Testing Ramipril to Prevent Memory Loss in People With Glioblastoma — Completed
• PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy — Running, not enrolling
• Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer — Paused
• R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma — Status unconfirmed
• TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery — Status unconfirmed
• T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer — Withdrawn before enrolling
• A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer — Status unconfirmed
• Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations — Completed
• Oxybutynin Chloride in Managing Hot Flashes — Completed
• Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome — Completed